Sharon Rosenzweig‐Lipson

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

Robert H. Ring, Jessica E. Malberg, Lisa Potestio et al. · Psychopharmacology · 2006 · 322 citations

Medicine, Behavioral Sciences, Neuroscience +14

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes

Stacey J. Sukoff Rizzo, Zoë A. Hughes, Mercedes Beyna et al. · Translational Psychiatry · 2012 · 235 citations · Full text

Medicine, Neuroscience, Psychiatry +17

Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466

Lee E. Schechter, Qian Lin, Deborah L. Smith et al. · Neuropsychopharmacology · 2007 · 218 citations

Medicine, Neuroscience, Pharmacology +13

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

Darrick T. Balu, Brian A. Hoshaw, Jessica E. Malberg et al. · Brain Research · 2008 · 193 citations

Medicine, Neurobiology, Neuroscience +11

ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

Feng Liu, Steve Grauer, Cody Kelley et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 182 citations

Medicine, Neuroscience, Pharmacology +17